Fisher & Paykel Healthcare’s revenue for the half year to 30 September (it has a 31 March year end) grew 6% to NZ$267m. Net profit jumped a far more impressive 18% to NZ$33m (even higher in constant currency terms). An interim dividend of NZ 5.4 cents was declared (ex date 27 Nov 12), in line with last year. Non-NZ shareholders will also receive a bonus 0.9526 NZ cents per share in lieu of New Zealand input tax credits.
F&P Healthcare’s Respiratory and Acute Care division—which sells breathing devices for use in hospitals—contributed most of the headline growth, with sales up 9% to $143m.